[Table/Fig-1]:
Class | Limitation |
---|---|
β-lactam | No activity against atypical pathogen and development of S. pneumoniae resistant isolates > 50 % |
Macrolides | 30.9 % resistant S. pneumoniae isolates reported |
Fluroquinolones | Increase potential for emergence of resistant strain of gram negative microorganism |